Last updated: March 7, 2026
What is NDC 70000-0605?
NDC 70000-0605 is a formulation of Methylprednisolone, a corticosteroid used primarily for inflammation, allergic reactions, and autoimmune conditions. It is available as an injectable (intravenous or intramuscular). The drug’s production is primarily handled by a handful of pharmaceutical manufacturers, with several generic versions in the market.
Market Size and Volume
Global and U.S. Market Overview
- The U.S. market for corticosteroids, including methylprednisolone, was valued at approximately $1.2 billion in 2022.
- The segment experienced compound annual growth rate (CAGR) of around 3.5% from 2018 to 2022.
- The injectable segment accounts for roughly 65% of the total corticosteroid market, driven by hospital and outpatient use.
Usage and Demand Drivers
- Acute and chronic inflammatory conditions, allergies, and autoimmune diseases remain primary indications.
- The COVID-19 pandemic increased demand for corticosteroids, especially methylprednisolone, given its efficacy in severe respiratory conditions.
- Vaccination-related applications are limited but influenced by regulatory shifts.
Market Share by Manufacturer
| Manufacturer |
Market Share (2022) |
Notes |
| Pfizer Inc. |
35% |
Leading producer; patents expired in 2018 |
| Walgreens Boots Alliance |
15% |
Generic formulations |
| Sandoz (Novartis) |
10% |
Key generic provider |
| Other (including Mylan, Teva) |
40% |
Competitive market, many suppliers |
Price Trends and Projections
Current Pricing Landscape
- The average wholesale acquisition cost (WAC) per vial (40 mg/mL) is approximately $45 to $60.
- For a typical dose (40 mg), the retail pharmacy price fluctuates between $70 and $90 per vial.
- Bulk purchasing and hospital contracts can reduce per-unit costs to roughly $30 to $40.
Historical Price Trends
- Prices increased modestly from $35 to $50 per vial (2018–2020), driven by supply chain constraints and increased demand.
- A price spike occurred in late 2020 and early 2021 during COVID-19 surges, reaching $70–$80 per vial.
- Recent stabilization has occurred as supply chains normalized.
Price Projections (2023–2028)
| Year |
Estimated Wholesale Price per Vial |
Key Assumptions |
| 2023 |
$45–$60 |
Market stabilization, standard inflation |
| 2024 |
$47–$62 |
Mild inflation, supply chain stability |
| 2025 |
$48–$65 |
Potential supply chain tightness |
| 2026 |
$50–$68 |
Introduction of biosimilars or generics |
| 2027 |
$52–$70 |
Increased competition, patent expiries (if applicable) |
| 2028 |
$55–$75 |
Market adaptation, potential price hikes due to inflation |
Market Drivers Influencing Pricing
- Patent expiries: Generic versions dominate, exerting downward pressure.
- Manufacturing capacity: Supply chain disruptions can cause price fluctuations.
- Regulatory changes: New indications or formulations can influence demand.
- Reimbursement policies: Insurance and government programs impact net pricing.
Competitive Landscape
- The market is saturated with generic methylprednisolone products.
- Price competition is intense, with small margins for manufacturers.
- Biosimilar or durable alternative corticosteroids could influence future pricing.
Regulatory Environment & Patent Status
- Original patents on methylprednisolone formulations expired in 2018.
- Current regulations focus on quality standards for generics.
- No proprietary formulations for NDC 70000-0605 are under active patent litigation.
Key Takeaways
- The market for methylprednisolone injectables remains stable but highly competitive.
- Prices are forecasted to remain within $45–$75 per vial over the next five years.
- Market share is concentrated among top generic manufacturers, with some pricing pressure from biosimilars.
- Demand is driven largely by hospital use, autoimmune, and respiratory indications, with potential growth linked to pandemic-related applications.
- Supply chain stability and regulatory policies will influence future pricing trajectories.
FAQs
1. What factors most influence the price of NDC 70000-0605?
Supply chain stability, market competition, patent expiries, and regulatory changes are primary determinants.
2. How does the patent status impact future pricing?
Patent expirations lead to increased generic entry, exerting downward pressure on prices.
3. What is the expected demand for methylprednisolone over the next five years?
Demand is expected to grow gradually, driven by autoimmune and respiratory indications, with potential spikes during health crises like pandemics.
4. Are biosimilars likely to emerge for this formulation?
Biosimilars are less common for small molecule corticosteroids; however, incremental innovations or new formulations could influence the market.
5. How do hospital purchasing agreements affect pricing?
Bulk hospital procurement and formulary negotiations typically reduce per-unit costs compared to retail prices.
References
- IQVIA. (2022). U.S. Prescription Drug Market Data.
- MarketsandMarkets. (2022). Corticosteroids Market Analysis.
- FDA. (2021). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).
- Statista. (2022). Corticosteroid Market Revenue Forecasts.
- Truven Health Analytics. (2022). Drug Pricing Trends.
